NATCO Pharma Ltd. · NATCOPHARM
Every NATCO Pharma Ltd. result whose ten-session window has closed, judged against the last read made before it. Sector index NIFTY HEALTHCARE INDEX. Open a result for the full account: the read, the sessions after, the reported figures, and every morning's read that led up to it. The company's own page →
24results judged
0read right
4read wrong
1flat / no call
19unread
38%beat the market
-0.8%avg vs market, 10d
4.6%avg move, T+1
How the reads on it fared
| Read | Judged | Right | Wrong | Flat | Hit rate | Avg vs mkt | |
|---|---|---|---|---|---|---|---|
| strong | 2 | 0 | 2 | 0 | 0% | -10.3% | |
| neutral | 1 | 0 | 0 | 1 | — | +10.1% | |
| unfavourable | 2 | 0 | 2 | 0 | 0% | +13.4% | |
| unread | 19 | 0 | 0 | 0 | — | -1.9% |
A company that is often read strong and often proves it is one the model understands; one that is read strong and keeps lagging is where the model is wrong about a name, and this table is where that shows first.
Reading the rows
- T+1
- the share's move on the first session after the result, from the close before it
- T+10
- the move over ten sessions, same base
- vs market
- T+10 less NIFTY 50's move over the same ten sessions — the number every read is judged on
- Run-up
- the share's move in the thirty sessions before the result
- Result
- reported profit growth against the company's own last four quarters: good, in line, bad
Each result
24 judged · newest first · open one| Result | Read | Outcome | T+1 | T+10 | vs market | Run-up | Result | Why | |
|---|---|---|---|---|---|---|---|---|---|
| 14 Aug Q1FY27 | — | unread | -0.5% | -6.8% | -5.7% | -3% | no figures |
|
› |
| 29 May Q4FY26 | strong | wrong | -7.5% | -16.6% | -17.9% | -7% | no figures |
|
› |
| 12 Feb Q3FY26 | unfavourable | wrong | +5.0% | +17.7% | +20.1% | -7% | no figures |
|
› |
| 14 Nov Q2FY26 | neutral | neutral | +0.2% | +11.1% | +10.1% | +2% | no figures |
|
› |
| 12 Aug Q1FY26 | strong | wrong | -1.6% | -3.0% | -2.7% | -5% | no figures |
|
› |
| 28 May Q4FY25 | unfavourable | wrong | +2.4% | +7.2% | +6.6% | +11% | no figures |
|
› |
| 12 Feb Q3FY25 | — | unread | -27.5% | -36.8% | -32.8% | -13% | no figures |
|
› |
| 12 Nov Q2FY25 | — | unread | -1.0% | -3.8% | -4.0% | -2% | no figures |
|
› |
| 12 Aug Q1FY25 | — | unread | -2.4% | +3.0% | +0.1% | +28% | no figures |
|
› |
| 27 May Q4FY24 | — | unread | +1.2% | +13.9% | +12.4% | +4% | no figures |
|
› |
| 14 Feb Q3FY24 | — | unread | +16.0% | +12.5% | +11.8% | +8% | no figures |
|
› |
| 14 Nov Q2FY24 | — | unread | -2.6% | -0.2% | -3.8% | -9% | no figures |
|
› |
| 9 Aug Q1FY24 | — | unread | -5.1% | -1.0% | +0.8% | +30% | no figures |
|
› |
| 29 May Q4FY23 | — | unread | -2.3% | -1.7% | -1.8% | +10% | no figures |
|
› |
| 9 Feb Q3FY23 | — | unread | +0.8% | +1.9% | +4.3% | -5% | no figures |
|
› |
| 10 Nov Q2FY23 | — | unread | -2.5% | -3.7% | -6.4% | -2% | no figures |
|
› |
| 31 May Q4FY22 | — | unread | +6.7% | +0.6% | +6.2% | -18% | no figures |
|
› |
| 14 Feb Q3FY22 | — | unread | -3.9% | -5.2% | -3.8% | +1% | no figures |
|
› |
| 11 Nov Q2FY22 | — | unread | +2.6% | -0.1% | +4.5% | -7% | no figures |
|
› |
| 12 Aug Q1FY22 | — | unread | -5.1% | -8.9% | -12.4% | -8% | no figures |
|
› |
| 17 Jun Q4FY21 | — | unread | +1.3% | +6.3% | +6.1% | +16% | no figures |
|
› |
| 11 Feb Q3FY21 | — | unread | -5.0% | -8.5% | -4.2% | -8% | no figures |
|
› |
| 12 Nov Q2FY21 | — | unread | — | +1.7% | -0.5% | -3% | no figures |
|
› |
| 12 Aug Q1FY21 | — | unread | -2.3% | -4.3% | -6.6% | +33% | no figures |
|
› |